It is time to rethink H. pylori therapy
- PMID: 28617879
- PMCID: PMC6905079
- DOI: 10.15403/jgld.2014.1121.262.hpy
It is time to rethink H. pylori therapy
Conflict of interest statement
Comment on
-
Eradication rates in Italian subjects heterogeneously managed for Helicobacter pylori infection. Time to abandon empiric treatments in Southern Europe.J Gastrointestin Liver Dis. 2017 Jun;26(2):129-137. doi: 10.15403/jgld.2014.1121.262.itl. J Gastrointestin Liver Dis. 2017. PMID: 28617882
References
-
- Di Ciaula A, Scaccianoce G, Venerito M, et al. Eradication rates in Italian subjects heterogeneously managed for Helicobacter pylori infection. Time to abandon empiric treatments in Southern Europe. J Gastrointestin Liver Dis 2017;26. - PubMed
-
- Yamaoka Y, Graham DY, Lu H. Should triple therapy for Helicobacter pylori infection be abandoned as no longer effective? US Gastroenterology 2008;4:65–67.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
